Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Upadacitinib may effectively treat resistant lichen planopilaris.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Tofacitinib may effectively treat folliculitis decalvans.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

The combination therapy was effective and well-tolerated, especially in young patients.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Tofacitinib taken by mouth helps treat hair loss in children.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.